| First Author | Naraiah Mukkala A | Year | 2023 |
| Journal | Mitochondrion | Volume | 70 |
| Pages | 20-30 | PubMed ID | 36906251 |
| Mgi Jnum | J:355543 | Mgi Id | MGI:7719072 |
| Doi | 10.1016/j.mito.2023.03.002 | Citation | Naraiah Mukkala A, et al. (2023) Augmented Parkin-dependent mitophagy underlies the hepatoprotective effect of remote ischemic conditioning used prior to hemorrhagic shock. Mitochondrion 70:20-30 |
| abstractText | BACKGROUND AND AIMS: Hemorrhagic shock-resuscitation (HSR) following trauma contributes to organ dysfunction by causing ischemia-reperfusion injury (IRI). We previously showed that 'remote ischemic preconditioning' (RIPC) exerted multi-organ protection from IRI. Maintenance of mitochondrial quality by clearance of dysfunctional mitochondria via mitophagy is vital in restoring organ integrity. We hypothesized that parkin-dependent mitophagy played a role in RIPC-induced hepatoprotection following HSR. METHODS: The hepatoprotective effect of RIPC in a murine model of HSR-IRI was investigated in wild type and parkin-/- animals. Mice were subjected to HSR +/- RIPC and blood and organs were collected, followed by cytokine ELISAs, histology, qPCR, Western blots, and transmission electron microscopy. RESULTS: HSR increased hepatocellular injury, as measured by plasma ALT and liver necrosis, while antecedent RIPC prevented this injury; in parkin(-/-) mice, RIPC failed to exert hepatoprotection. The ability of RIPC to lessen HSR-induced rises in plasma IL-6 and TNFalpha, was lost in parkin(-/-) mice. While RIPC alone did not induce mitophagy, the application of RIPC prior to HSR caused a synergistic increase in mitophagy, this increase was not observed in parkin(-/-) mice. RIPC induced shifts in mitochondrial morphology favoring mitophagy in WT but not in parkin(-/-) animals. CONCLUSIONS: RIPC was hepatoprotective in WT mice following HSR but not in parkin(-/-) mice. Loss of protection in parkin(-/-) mice corresponded with the failure of RIPC plus HSR to upregulate the mitophagic process. Improving mitochondrial quality by modulating mitophagy, may prove to be an attractive therapeutic target in disease processes caused by IRI. |
